References
- Kuczmarski R J, Flegal K M, Campbell S M, Johnson C L. Increasing prevalence of overweight among US adults. A National Health and Nutrition Examination Survey, 1960–1991. JAMA 1994; 272: 205–211
- Sowers M, Zheng H, Tomey K, et al. Changes in body composition in women over 6 years at mid life: ovarian and chronological aging. J Clin Endocrinol Metab 2006, Dec 27 (Epub ahead of print)
- Poehlman E T, Toth M J, Gardner A W. Changes in energy balance and body composition at menopause. Ann Intern Med 1995; 123: 673–675
- Guthrie J R, Dennerstein L, Taffe J R, et al. Central abdominal fat and endogenous hormones during the menopausal transition. Fertil Steril 2003; 79: 1335–1334
- Genazzani A R, Gambacciani M. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 2006; 22: 145–150
- Strothmann A, Schneider H PG. Hormone therapy: the European woman's perspective. Climacteric 2003; 6: 337–346
- The Writing Group for the PEPI trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995; 273: 199–208
- Norman R J, Flight I HK, Rees M CP. Oestrogen and progestogen hormone replacement therapy for perimenopausal and postmenopausal women: weight and body fat distribution (Cochrane review). The Cochrane Library. Update software, Oxford 2001; 3
- Reubinoff B E, Wurtman J, Rojansky N, et al. Effects of hormone replacement therapy on weight, body composition, fat distribution and food intake in early postmenopausal women: a prospective study. Fertil Steril 1995; 64: 963–968
- Archer D F, Thorneycroft I H, Foegh M, et al. Long-term safety of drospirenone–estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause 2005; 12: 716–727
- Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
- The Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–1712
- Cushman M, Kuller L H, Prentice R, et al. Estrogen plus progestin and risk of venous thrombosis. JAMA 2004; 292: 1573–1580